Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Bonavida

Showing results (131-140 of 192) with videos related to

Pageof 20
Sort By:
Oncology Reports|February 12, 2002
Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancerYoichi Mizutani, Hiromi Wada, Osamu Yoshida, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulationStavroula Baritaki, Alina Katsman, Devasis Chatterjee, et al.
Nitric Oxide : Biology and Chemistry|January 30, 2013
Nitric oxide-mediated activity in anti-cancer photodynamic therapyValentina Rapozzi, Emilia Della Pietra, Sonia Zorzet, et al.
Nitric Oxide : Biology and Chemistry|May 15, 2008
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastasesBenjamin Bonavida, Stavroula Baritaki, Sara Huerta-Yepez, et al.
International Journal of Oncology|March 25, 2008
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in gliomaAyhan Bilir, Mine Erguven, Gulperi Oktem, et al.
Oncogene|April 13, 2004
Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistanceMario I Vega, Sara Huerta-Yepaz, Hermes Garban, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
Quantitative structure-activity relationships of phenolic compounds causing apoptosisCorwin Hansch, Benjamin Bonavida, Ali R Jazirehi, et al.
Cell Cycle (Georgetown, Tex.)|December 15, 2010
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIPStavroula Baritaki, Sara Huerta-Yepez, Anna Sahakyan, et al.
Oncogene|March 30, 2004
Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expressionSara Huerta-Yepez, Mario Vega, Ali Jazirehi, et al.
Advances in Cancer Research|April 17, 2007
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implicationsStavroula Baritaki, Stavros Apostolakis, Peggy Kanellou, et al.
Pageof 20

Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
Oncology Reports|February 12, 2002
Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancerYoichi Mizutani, Hiromi Wada, Osamu Yoshida, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulationStavroula Baritaki, Alina Katsman, Devasis Chatterjee, et al.
Nitric Oxide : Biology and Chemistry|January 30, 2013
Nitric oxide-mediated activity in anti-cancer photodynamic therapyValentina Rapozzi, Emilia Della Pietra, Sonia Zorzet, et al.
Nitric Oxide : Biology and Chemistry|May 15, 2008
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastasesBenjamin Bonavida, Stavroula Baritaki, Sara Huerta-Yepez, et al.
International Journal of Oncology|March 25, 2008
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in gliomaAyhan Bilir, Mine Erguven, Gulperi Oktem, et al.
Oncogene|April 13, 2004
Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistanceMario I Vega, Sara Huerta-Yepaz, Hermes Garban, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
Quantitative structure-activity relationships of phenolic compounds causing apoptosisCorwin Hansch, Benjamin Bonavida, Ali R Jazirehi, et al.
Cell Cycle (Georgetown, Tex.)|December 15, 2010
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIPStavroula Baritaki, Sara Huerta-Yepez, Anna Sahakyan, et al.
Oncogene|March 30, 2004
Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expressionSara Huerta-Yepez, Mario Vega, Ali Jazirehi, et al.
Advances in Cancer Research|April 17, 2007
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implicationsStavroula Baritaki, Stavros Apostolakis, Peggy Kanellou, et al.
Pageof 20